• English
  • Greek
  • Russian

Paphitou Niki, MD

Specialty
Intensive Care Medicine, Infectious Diseases
Medical School

National and Kapodistrian University of Athens Medical School, Athens, Greece.

Internship

Internal Medicine, Wright State University, Dayton, Ohio, USA.

Residency

Internal Medicine, Wright State University, Dayton, Ohio, USA.

Fellowships
  • Infectious Diseases Fellowship, University of Texas at Houston/MD Anderson Cancer Center, Houston, Texas, USA.
  • Critical Care Medicine Fellowship, Baylor College of Medicine, Houston, Texas, USA.
Certification
  • Board certified, American Board of Internal Medicine in Internal Medicine.
  • Board certified, American Board of Internal Medicine in Infectious Disease.
  • Board certified, American Board of Internal Medicine in Critical Care Medicine.
  • Fellow, Royal College of Physicians and Surgeons of Canada, Internal Medicine.
Academic Interests

Risk factors for invasive fungal infections in critically ill patients, multidrug resistant bacterial infections. Antimicrobial resistance, antimicrobial stewardship, infection control in the acute care setting. Development of infection control guidelines, development of antimicrobial use guidelines.
Professional Highlights

Professional Highlights
  • Member of the European Center for Disease Control (ECDC) Advisory Forum, Cyprus Representative.
  • Cyprus Antimicrobial Resistance National Focal Point and Cyprus Representative for Antimicrobial Resistance at ECDC.
  • President, Cyprus National Antibiotics Committee.
    National Antimicrobial Resistance Surveillance System
  • Coordinator.  Annual European Antibiotic Awareness Campaign, Coordinator for Cyprus.
  • Coordinator, Cyprus National Antibiotics Committee Working Group for antibiotic use guideline development.
  • Coordinator, Cyprus National Infection Control Guideline Development.
  • AUTHORSHIP OF NATIONAL GUIDELINES, STRATEGIES, REPORTS:
  • Author, Cyprus National Strategy to Combat Antimicrobial Resistance.
  • Author / Co-Author, CY National Infection Control Guidelines.
  • Statistical analysis and authorship of the annual CY National Antimicrobial Resistance Surveillance System reports.
  • Author, Chapters BCG Vaccination and TB Prevention and Control, Cyprus National Strategy for Tuberculosis Management.
Publications

Paphitou NI. 
Antimicrobial resistance: action to combat the rising microbial challenges. Int J Antimicrob Agents. 2013 Jun;42 Suppl:S25-8. Review.
Paphitou NI, Ostrosky-Zeichner L, Rex JH.
Rules for identifying patients at increased risk for candidal infections in the surgical intensive care unit: An approach to developing practical criteria for systematic use in antifungal prophylaxis trials. Med Mycol. 2005 May;43(3):235-43.
Paphitou NI, Ostrosky-Zeichner L, Paetznick VL, Rodriguez JR, Chen E, Rex JH.
In Vitro Antifungal Susceptibilities of Trichosporon species. Antimicrobial Agents and Chemotherapy, 2002, 46;(4): 1144-1146.
Paphitou NI, Barnett BJ.
Solitary Parietal Lobe Histoplasmoma Mimicking a Brain Tumor.Scandinavian Journal of Infectious Diseases, 2002, 34;(3): 229-232.
Paphitou NI, Ostrosky-Zeichner L, Paetznick VL, Rodriguez JR, Chen E, Rex JH.
In Vitro Activity of Investigational Triazoles against Fusarium: Effects of Inoculum size and Time of Reading on Broth Microdilution Susceptibility Test Results. Antimicrobial Agents and Chemotherapy, 2002, 46;(10): 3298-3300.
Paphitou NI, Rolston KV.
Agrobacterium Radiobacter Bacteremia: Report of a Case and Literature Review of Agrobacterium Infections in Humans. Infection, 2003 Dec;31(6):421-4.
Nannini EC, Paphitou NI, Ostrosky-Zeichner L.
Peritonitis Due to Aspergillus and Zygomycetes in Patients Undergoing Peritoneal dialysis: Report of 2 Cases and Review of the Literature. Diagnostic Microbiology and Infectious Diseases, 2003 May;46(1):49-54.

Contact Info

215, Spyrou Kyprianou Ave.
2047 Strovolos
P.O. Box 25610, 1311
Nicosia, Cyprus

Tel: + 357 22 476 799
Fax: + 357 22 322 660
Email: elpnik@gmail.com